11-74456329-CAAAAA-CAAAAAAAAA
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_005472.5(KCNE3):c.*919_*922dupTTTT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.070 ( 342 hom., cov: 0)
Exomes 𝑓: 0.17 ( 0 hom. )
Consequence
KCNE3
NM_005472.5 3_prime_UTR
NM_005472.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.554
Publications
1 publications found
Genes affected
KCNE3 (HGNC:6243): (potassium voltage-gated channel subfamily E regulatory subunit 3) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, isk-related subfamily. This member is a type I membrane protein, and a beta subunit that assembles with a potassium channel alpha-subunit to modulate the gating kinetics and enhance stability of the multimeric complex. This gene is prominently expressed in the kidney. A missense mutation in this gene is associated with hypokalemic periodic paralysis. [provided by RefSeq, Jul 2008]
KCNE3 Gene-Disease associations (from GenCC):
- Brugada syndrome 6Inheritance: Unknown, AD Classification: LIMITED, NO_KNOWN Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Brugada syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.125 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005472.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNE3 | NM_005472.5 | MANE Select | c.*919_*922dupTTTT | 3_prime_UTR | Exon 3 of 3 | NP_005463.1 | Q9Y6H6 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNE3 | ENST00000310128.9 | TSL:1 MANE Select | c.*919_*922dupTTTT | 3_prime_UTR | Exon 3 of 3 | ENSP00000310557.4 | Q9Y6H6 | ||
| KCNE3 | ENST00000875764.1 | c.*919_*922dupTTTT | 3_prime_UTR | Exon 4 of 4 | ENSP00000545823.1 | ||||
| KCNE3 | ENST00000929452.1 | c.*919_*922dupTTTT | 3_prime_UTR | Exon 4 of 4 | ENSP00000599511.1 |
Frequencies
GnomAD3 genomes AF: 0.0703 AC: 8471AN: 120426Hom.: 343 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
8471
AN:
120426
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.172 AC: 10AN: 58Hom.: 0 Cov.: 0 AF XY: 0.214 AC XY: 9AN XY: 42 show subpopulations
GnomAD4 exome
AF:
AC:
10
AN:
58
Hom.:
Cov.:
0
AF XY:
AC XY:
9
AN XY:
42
show subpopulations
African (AFR)
AF:
AC:
0
AN:
4
American (AMR)
AF:
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
AC:
0
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
10
AN:
50
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.415
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0703 AC: 8460AN: 120414Hom.: 342 Cov.: 0 AF XY: 0.0730 AC XY: 4158AN XY: 56960 show subpopulations
GnomAD4 genome
AF:
AC:
8460
AN:
120414
Hom.:
Cov.:
0
AF XY:
AC XY:
4158
AN XY:
56960
show subpopulations
African (AFR)
AF:
AC:
1238
AN:
31364
American (AMR)
AF:
AC:
609
AN:
11870
Ashkenazi Jewish (ASJ)
AF:
AC:
208
AN:
3102
East Asian (EAS)
AF:
AC:
286
AN:
4146
South Asian (SAS)
AF:
AC:
485
AN:
3608
European-Finnish (FIN)
AF:
AC:
579
AN:
5422
Middle Eastern (MID)
AF:
AC:
38
AN:
238
European-Non Finnish (NFE)
AF:
AC:
4785
AN:
58210
Other (OTH)
AF:
AC:
108
AN:
1644
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
336
672
1008
1344
1680
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
1
-
Brugada syndrome (1)
-
1
-
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.